About Hemolytic anemia due to diphosphoglycerate mutase deficiency
Hemolytic anemia due to diphosphoglycerate mutase deficiency is a rare disease catalogued by Orphanet (ORPHA:714). It is associated with the BPGM gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Hemolytic anemia due to diphosphoglycerate mutase deficiency trials.
Search ClinicalTrials.gov for "Hemolytic anemia due to diphosphoglycerate mutase deficiency" or filter by Orphanet code ORPHA:714 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Hemolytic anemia due to diphosphoglycerate mutase deficiency trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Hemolytic anemia due to diphosphoglycerate mutase deficiency. Updated daily.